Evidence map›Paper›PMID 42877466›Full record

ReviewTaiwan journal of ophthalmology

Neuroimaging in neuro-ophthalmologic emergencies with acute visual loss.

Wei-Ling Lin, Rong-Kung Tsai

Abstract readReview
In one paragraph

Review in Taiwan journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wei-Ling LinDepartment of Ophthalmology, China Medical University Hospital, China Medical University, Taichung, Taiwan.
Rong-Kung TsaiInstitute of Eye Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuro-ophthalmologic emergencies presenting with acute visual loss pose significant diagnostic and therapeutic challenges, with potential for irreversible vision loss if not promptly recognized. A comprehensive approach that integrates clinical evaluation with advanced imaging modalities is essential for timely diagnosis, prognostic stratification, and management. Magnetic resonance imaging remains the gold standard for demyelinating optic neuritis, enabling differentiation among multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease through lesion morphology and distribution, and is definitive for diagnosing pituitary apoplexy through the detection of sellar hemorrhage or infarction. Computed tomography is indispensable in the emergent triage of orbital trauma and in the rapid exclusion of intracranial hemorrhage in acute stroke. Optical coherence tomography (OCT) provides high-resolution quantification of neuroaxonal injury, with macular ganglion cell-inner plexiform layer thinning serving as a sensitive early marker of permanent damage compared to peripapillary retinal nerve fiber layer changes. OCT angiography further enhances vascular assessment in ischemic optic neuropathies and giant cell arteritis (GCA), offering a noninvasive alternative to fluorescein angiography. Ultrasonography contributes to the evaluation of GCA through the detection of the "halo sign" and provides bedside utility for measuring optic nerve sheath diameter in suspected intracranial hypertension. This narrative review highlights the complementary roles of these imaging techniques, underscoring their strategic application in optimizing outcomes for vision-threatening neuro-ophthalmologic emergencies.

Indexed as

Acute visual lossneuroimagingneuro-ophthalmologic emergencyoptical coherence tomographyoptical coherence tomography angiography

Identifiers

PMID42877466
PMCPMC13668188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.